VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 89 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,298,000 | +119.6% | 72,464 | +100.0% | 0.02% | -16.7% |
| Q2 2017 | $591,000 | +16.6% | 36,232 | 0.0% | 0.03% | +3.4% |
| Q1 2017 | $507,000 | -15.6% | 36,232 | -49.6% | 0.03% | -45.3% |
| Q1 2016 | $601,000 | -10.2% | 71,849 | 0.0% | 0.05% | +8.2% |
| Q4 2015 | $669,000 | -64.0% | 71,849 | -64.1% | 0.05% | -66.0% |
| Q1 2015 | $1,860,000 | -81.4% | 200,000 | -71.4% | 0.14% | -82.9% |
| Q4 2014 | $10,024,000 | +38.0% | 700,000 | 0.0% | 0.84% | +7.8% |
| Q3 2014 | $7,266,000 | -77.1% | 700,000 | -75.8% | 0.78% | -40.2% |
| Q3 2013 | $31,702,000 | – | 2,895,200 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |